FDA.reportPublic FDA data

Application 212598

Type
ANDA
Sponsor
AUROBINDO PHARMA LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FENOFIBRIC ACIDCHOLINE FENOFIBRATECAPSULE, DELAYED RELEASE;ORALEQ 45MG FENOFIBRIC ACIDNoNo
002FENOFIBRIC ACIDCHOLINE FENOFIBRATECAPSULE, DELAYED RELEASE;ORALEQ 135MG FENOFIBRIC ACIDNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A212598-001FENOFIBRIC ACIDCHOLINE FENOFIBRATEEQ 45MG FENOFIBRIC ACIDCAPSULE, DELAYED RELEASE / ORALAB2019-07-25
A212598-002FENOFIBRIC ACIDCHOLINE FENOFIBRATEEQ 135MG FENOFIBRIC ACIDCAPSULE, DELAYED RELEASE / ORALABRS2019-07-25

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A212598-001AB
A212598-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A212598-001FENOFIBRIC ACIDEQ 45MG FENOFIBRIC ACIDCAPSULE, DELAYED RELEASE / ORALAB2019-07-25a50c72e98297…
2026-08-01 22:54:322026-06A212598-002FENOFIBRIC ACIDEQ 135MG FENOFIBRIC ACIDCAPSULE, DELAYED RELEASE / ORALABRS2019-07-25a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06A212598-001AB1a50c72e98297…
2026-08-01 22:54:322026-06A212598-002AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FENOFIBRIC ACIDFENOFIBRIC ACIDAurobindo Pharma Limited9ad201de-fa62-4c49-bc61-ee09b9ba434c2025-08-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 212598
application number: ANDA212598
ndc (product): 59651-217
ndc (product): 59651-216

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 9 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-5369FENOFIBRIC ACIDFENOFIBRIC ACIDA-S Medication SolutionsANDACurrent
59651-216FENOFIBRIC ACIDFENOFIBRIC ACIDAurobindo Pharma LimitedANDACurrent
59651-216FENOFIBRIC ACIDFENOFIBRIC ACIDAurobindo Pharma LimitedANDACurrent
59651-216FENOFIBRIC ACIDFENOFIBRIC ACIDAurobindo Pharma LimitedANDACurrent
59651-216FENOFIBRIC ACIDFENOFIBRIC ACIDAurobindo Pharma LimitedANDACurrent
59651-217FENOFIBRIC ACIDFENOFIBRIC ACIDAurobindo Pharma LimitedANDACurrent
59651-217FENOFIBRIC ACIDFENOFIBRIC ACIDAurobindo Pharma LimitedANDACurrent
59651-217FENOFIBRIC ACIDFENOFIBRIC ACIDAurobindo Pharma LimitedANDACurrent
59651-217FENOFIBRIC ACIDFENOFIBRIC ACIDAurobindo Pharma LimitedANDACurrent